Title for MeetingAbstracts
Alphabetical listing of titles
Prophylactic vaccine trials: what is different about HIV?
Prophylaxis after non occupational HIV exposure : an overview of the policies implemented in 27 European countries.
Prophylaxis against HIV-1 infection in chimpanzees by nevirapine (Viramune).
Prophylaxis against HIV-related opportunistic infections among adults in developing countries.
Prophylaxis against Mycobacterium avium complex (MAC) in HIV: application of guidelines.
Prophylaxis and seroconversion after occupational exposure to blood borne viruses in Australian health care workers.
Prophylaxis and treatment of opportunistic viral infections in patients with HIV infection.
Prophylaxis for mycobacterium avium complex can be deferred among patients with a past CD4 count <50 cells/mm3 who responded to antiretroviral therapy: results of a placebo-controlled trial (CPCRA 048).
Prophylaxis for Pneumocystis and survival in advanced HIV infection treated with zidovudine.
Prophylaxis for Pneumocystis carinii pneumonia (PCP) with aerosol pentamidine (AP) or oral dapsone (OD) in patients with AIDS or severe ARC.
Prophylaxis for Pneumocystis carinii pneumonia (PCP): a cost-effectiveness analysis.
Prophylaxis for Sexual Violence pos-exposure.
Prophylaxis in the ICU: New Approaches.
Prophylaxis issues in developing countries.
Prophylaxis of CMV retinitis relapse : evaluation of foscarnet in maintenance therapy.
Prophylaxis of fungal infection in HIV infection.
Prophylaxis of HSV-, VZV- and EBV-infections in HIV-infected patients.
Prophylaxis of perinatal HIV transmission in a general hospital in Buenos Aires.
Prophylaxis of Pneumocystis carinii pneumonia (PCP) with dapsone: an evaluation of toxicity and cross-reactivity with trimethoprim-sulfamethoxazole.
Prophylaxis of pneumocystis carinii pneumonia.
Prophylaxis of tuberculosis infection.
Prophylaxis of visceral leishmaniasis (VL) in HIV-infected patients.
Prophylaxis with cotrimoxazole and isoniazid in HIV-infected patients with smear-positive tuberculosis: MOIPMA trial.
Prophylaxis: to cease or not to cease--that is the question. Cessation of prophylactic therapy for opportunistic infections in patients with HIV/AIDS.
Propionibacterium acnes Infection Following Arthroplasty: 35 Cases.
Proportion of HIV/AIDS cases in coroner services in Sao Paulo, Brazil.
Proportion of Invasive Pneumococcal Disease Preventable by Vaccination in Dutch Children.
Proportion of new AIDS case reports attributable to the 1987 CDC revised surveillance case definition: Canada-United States differences.
Proportion positive for EBV,CMV,HHV-6, Toxoplasma, and HIV-1 in patients who are heterophile antibody negative with atypical lymphocytes, lymphocytosis, or both.
Proportional CD4+ cell decline and progression of HIV disease.